340B Hospitals Could See Audits On Use Of Drug Price Savings Under Biden Administration Proposal

Legislation would be needed and will be complicated to develop. While the effectiveness of existing audits has been question by a federal government watchdog, the proposal in Biden’s budget document suggests the administration has some sympathy with drug sponsors’ position in the ongoing fight over the 340B drug discount program.

Biden Administration May Persuade Democrats In Congress To Support Greater Transparency

More from Legislation

More from Pink Sheet